XML 20 R47.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Schedule II - Condensed Financial Information of Registrant, Statements of Cash Flows (Tables)
 12 Months Ended
Dec. 31, 2019
Condensed Financial Information Disclosure [Abstract]  
Condensed Cash Flow Statement
 
 
Years Ended December 31,
 
 
2019
 
2018
 
2017
 
 
(in thousands)
Operating activities
 
 
 
 
 
 
Net income
 
$
63,316

 
$
33,787

 
$
24,901

Adjustments to reconcile net income to net cash used in operating activities:
 
 
 
 
 
 
Deferred tax (benefit) expense
 
(150
)
 
(170
)
 
429

Stock compensation expense
 
2,742

 
1,597

 
652

Equity in undistributed earnings of subsidiaries
 
(61,315
)
 
(33,469
)
 
(25,303
)
Changes in operating assets and liabilities
 
(14,247
)
 
(633
)
 
(1,583
)
Dividends received from subsidiary
 
5,000

 
11,500

 
4,500

Net cash (used in) provided by operating activities
 
(4,654
)
 
12,612

 
3,596

 
 
 
 
 
 
 
Investing activities
 
 
 
 
 
 
Contributions to subsidiary
 
(68,391
)
 
—

 
—

Net cash used in investing activities
 
(68,391
)
 
—

 
—

 
 
 
 
 
 
 
Financing activities
 
 
 
 
 
 
Common stock issued, net of transaction costs
 
65,879

 
—

 
—

Common stock issued, stock options exercised
 
2,750

 
1,808

 
1,077

Payroll taxes withheld and remitted on share-based payments
 
(617
)
 
—

 
—

Dividends paid
 
(6,929
)
 
(5,906
)
 
(5,039
)
Proceeds from credit facility
 
17,300

 
—

 
—

Debt issuance costs
 
(628
)
 
—

 
—

Net cash provided by (used in) financing activities
 
77,755

 
(4,098
)
 
(3,962
)
Net change in cash and cash equivalents
 
4,710

 
8,514

 
(366
)
Cash and cash equivalents at beginning of year
 
10,016

 
1,502

 
1,868

Cash and cash equivalents at end of year
 
$
14,726

 
$
10,016

 
$
1,502